secwatch.observer — SEC 8-K summary
======================================

Issuer:     NewAmsterdam Pharma Co N.V. (NAMS)
CIK:        0001936258
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001193125-24-011701
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NewAmsterdam Pharma posts updated corporate presentation on website; no specific details disclosed
--------------------------------------------------------------------------------

- Updated corporate investor presentation posted to company website on January 22, 2024.
- Content of the updated presentation is not detailed in the public filing.
- No financial or operational changes were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1936258/000119312524011701/0001193125-24-011701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1936258/000119312524011701/d735106d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-011701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer